作者:Kozakiewicz-Piekarz, Anna、Grzegórska, Magdalena、Ziemkiewicz, Kamil、Grab, Katarzyna、Baranowski, Marek R.、Zapadka, Mariusz、Karpiel, Marta、Kupcewicz, Bogumiła、Kowalska, Joanna、Wujak, Magdalena
DOI:10.1016/j.bioorg.2024.107432
日期:——
Adenylate kinase (AK) plays a crucial role in the metabolic monitoring of cellular adenine nucleotide homeostasis by catalyzing the reversible transfer of a phosphate group between ATP and AMP, yielding two ADP molecules. By regulating the nucleotide levels and energy metabolism, the enzyme is considered a disease modifier and potential therapeutic target for various human diseases, including malignancies
腺苷酸激酶 (AK) 通过催化 ATP 和 AMP 之间磷酸基团的可逆转移,产生两个 ADP 分子,在细胞腺嘌呤核苷酸稳态的代谢监测中发挥着至关重要的作用。通过调节核苷酸水平和能量代谢,该酶被认为是一种疾病调节剂和多种人类疾病的潜在治疗靶点,包括恶性肿瘤、炎症和神经退行性疾病。然而,缺乏针对 AK 的批准药物阻碍了对该酶的病理重要性和治疗潜力的广泛研究。